Active ingredient production in Europe

13. October 2021

During the coronavirus pandemic, there were repeated bottlenecks in the supply of medicines. These arose in part from difficulties in supply chains outside Europe and led to a desire to minimise dependence on third countries.


Dr Konrad Schaefer, Division Manager Operational Experts at VTU Engineering, writes in his latest technical article in the renowned industry magazine PROCESS ONLINE about strategies to bring active ingredient manufacturing back to Europe.


Read the full article here.

© VTU Group - Published on 13. October 2021